Both in Pharmaceuticals
Sagimet Biosciences Inc. Series A vs Zevra Therapeutics
Over the past year SGMT returned +28.4% and ZVRA returned −6.7%; their daily moves had a correlation of 0.24.
SGMT +28.4% ZVRA −6.7%Growth of $1, one year, split-adjusted
| Metric | SGMT | ZVRA |
|---|---|---|
| Price | $9.99 | $10.36 |
| Market cap | $708.4M | $615.2M |
| Today | +2.57% | −1.05% |
| 1 month | −9.9% | −10.5% |
| 6 months | +59.1% | −1.2% |
| Year to date | +68.8% | +15.6% |
| 1 year | +27.6% | −7.1% |
| Revenue growth (YoY) | — | +53.3% |
| Gross margin | — | 96.2% |
| Net margin | — | 21.2% |
| P/E (TTM) | — | 10.6× |
| Price / sales | — | 4.5× |
| Net cash | $240.1M | $221.6M |
| Dividend yield | — | — |
| Volatility (60d) | 75.9% | 50.2% |
| Short % of float | 20.6% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).